Copyright
©The Author(s) 2020.
World J Gastroenterol. Apr 14, 2020; 26(14): 1580-1593
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1580
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1580
Targeting approach | Cancer model | Ref. |
CIK cells via NKG2D ligands expressed on CSC | Hepatocellular carcinoma | [56] |
NK cells via NKG2D ligands expressed on CSC | Pancreatic cancer | [57] |
CAR-T for CSC antigen ASB4 | Colon cancer | [59] |
CAR-T for EGFR and CAR-T for CSC antigen CD133 | Cholangiocarcinoma | [60] |
CAR-T for CSC antigen CD24 | Pancreatic adenocarcinoma | [61] |
DC loaded with Panc-1 CSC lysate | Pancreatic cancer | [62] |
DC loaded with total mRNA from gastric CSC | Gastric cancer | [63] |
- Citation: Chivu-Economescu M, Necula LG, Matei L, Dragu DL, Neagu AI, Alexiu I, Bleotu C, Diaconu CC. Gastrointestinal cancer stem cells as targets for innovative immunotherapy. World J Gastroenterol 2020; 26(14): 1580-1593
- URL: https://www.wjgnet.com/1007-9327/full/v26/i14/1580.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i14.1580